Hesperidin RCT in MS
Sponsored by Swansea University
About this trial
Last updated 3 months ago
Study ID
NECTAR-MS
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
Yes
Accepting
18+ Years
All Sexes
Trial Timing
Started 5 months ago
What is this trial about?
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress.
Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
What are the participation requirements?
Inclusion Criteria
* Diagnosis of Multiple Sclerosis, Aged 18 years or older.
Exclusion Criteria
* Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.